Drug Trial Radar · NCT03317743
Study to Assess the Safety & Tolerability of NOV140101(IDX-1197) in Patients With Advanced Solid Tumors
Last checked: Nov 19, 2026Latest source record: Apr 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
32
Actual
Start
Aug 29, 2017
Primary completion
Dec 8, 2020
Study completion Oct 13, 2021
Sponsor
- Lead sponsor
- Idience Co., Ltd.Industry
- Sponsor type
- Industry
- Collaborators
- IlDong Pharmaceutical Co Ltd; National OncoVenture
- First posted
- Oct 23, 2017
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
the purpose of this open-label, dose escalation-dose expansion, Phase 1 clinical trial is to evaluate the safety, pharmacokinetics and anti-tumor activity and determine the maximum tolerated dose (MTD) and recommended phase II dose (RP2D) of NOV140101 (IDX-1197).
Conditions
- Advanced Solid Tumors
Interventions
NOV140101 (IDX-1197)Drug
The dose levels will be escalated following a 3+3 dose escalation scheme.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Dose Limiting Toxicities (DLTs)Time frame: Subjects will be treated and observed for DLT through the end of the first cycle (Days 0-21)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Asan Medical Center
Seoul, SONGPA-GU, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.